Streetbeat News

Products Services

EOLS

Evolus, Inc. (NASDAQ:EOLS) has submitted the final module of its premarket approval application to the U.S. FDA for its Evolysse™ Lift and Evolysse™ Smooth dermal filler products targeting the nasolabial fold.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:09 pm

BOWL

Bowlero Corp. (NYSE:BOWL) announced that its Summer Season Pass has reached $6 million in sales to date, marking an all-time high for the company. This achievement underscores the growing popularity of the pass and Bowlero's commitment to providing value and entertainment.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:09 pm

IFRX

InflaRx shares are trading higher after the company announced that its drug GOHIBIC was selected by BARDA for a Phase 2 study on acute respiratory distress syndrome.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:09 pm

DUO

Fangdd Network Group shares are trading higher after the company announced plans to acquire cloud computing technology patents in China for $35 million.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:08 pm

ENLV

Enlivex Therapeutics Ltd. (NASDAQ: ENLV) has dosed the first patient in a Phase I/II trial for AllocetraTM, targeting thumb osteoarthritis. This trial aims to evaluate the safety and efficacy of AllocetraTM in up to 46 patients, with no current FDA-approved therapies for this condition.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:07 pm

RXRX

Recursion (NASDAQ:RXRX) provided updated guidance on seven clinical trial readouts expected within the next 18 months and shared partnership updates, including a collaboration with Bayer on oncology projects and the use of Recursion's LOWE for drug discovery.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:07 pm

ADTN

IRDM

Adtran and Iridium have announced the launch of their solutions featuring Iridium STL technology in Europe and Asia-Pacific. Adtran's Oscilloquartz solutions now support Iridium STL services, providing precise and secure timing via low-Earth orbit satellites. This is particularly important as cyber threats to GNSS grow, offering a robust alternative for 5G mobile operators and the defense sector.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:06 pm

DUO

FXI

Fangdd Network Group (DUO) is set to acquire cloud computer technology patents in China for $35 million. This move is part of their strategy to expand into tech-enabled real estate management. The seller is entitled to earnout payments up to $15 million based on revenue generated through 2026.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:05 pm

CRNC

VWAGY

Volkswagen Group has deployed Cerence Chat Pro, an AI-powered in-car assistant, to its European models. This marks the first time the solution is available to drivers, leveraging ChatGPT's large language model for enhanced conversational capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:04 pm

FDMT

4D Molecular Therapeutics (FDMT) announced that the FDA has cleared its IND application for 4D-175, a genetic medicine for treating geographic atrophy. The treatment uses a proprietary AAV vector and a codon-optimized transgene. Phase 1 clinical trial enrollment is expected to begin in H2 2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:04 pm